Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Debt / DBCV 0.250% 2/0
-
Market price (% of par)
-
93.57%
-
Total 13F principal
-
$406,709,306
-
Principal change
-
-$1,008,608
-
Total reported market value
-
$381,511,560
-
Number of holders
-
50
-
Value change
-
-$516,613
-
Number of buys
-
14
-
Number of sells
-
25
Institutional Holders of TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 as of Q3 2018
As of 30 Sep 2018,
TEVA PHARMACEUTICAL FIN LLC - DBCV 0.250% 2/0 was held by
50 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$406,709,306
in principal (par value) of the bond.
The largest 10 bondholders included
ADVENT CAPITAL MANAGEMENT /DE/, Allianz Asset Management GmbH, PRUDENTIAL PLC, Southpaw Asset Management LP, WELLS FARGO & COMPANY/MN, OAKTREE CAPITAL MANAGEMENT LP, INCOME RESEARCH & MANAGEMENT, AXA, Invesco Ltd., and STATE STREET CORP.
This page lists
50
institutional bondholders reporting positions
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.